Crowdonomics
All companies
KINEON logo

KINEON

Operating

Kineon, Inc.

Biotech · Biotech · Atlanta, GA · Founded 2021

Biotech company dedicated to changing the way we approach chronic pain through light therapy products

Post-money valuation ⓘ
$20.5M
As of Nov 2023 · from Reg CF Offering (2023) · pre-money + amount raised, not a traded price
Total raised
$459,677
Across 1 round since 2023
Latest share price
$1.00
Reg CF · Common Stock · Aug 2023 offering price

Financials

FY2021–FY2025 · from SEC filings · hover any figure for its source
$0
−$198K
2021
$1.3M
$22K
2022
$2.9M
−$107K
2023
$10.3M
−$1.9M
2024
$6.8M
−$506K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021 reviewed
FY2022 reviewed
FY2023 reviewed
FY2024 unaudited
FY2025
Income statement
Revenue
$0
$1,329,000
$2,887,269
$10,281,759
$6,785,478
Cost of goods sold
$0
$360,000
$549,768
$1,912,383
$1,279,184
Gross margin
—
73%
81%
81%
81%
Net income
-$197,792
$22,000
-$107,280
-$1,856,509
-$506,469
Taxes paid
$0
$0
$0
$0
$0
Balance sheet
Cash
$147,789
$66,000
$414,651
$488,585
$591,785
Accounts receivable
$0
$33,000
$0
$0
$48,547
Total assets
$157,078
$324,000
$905,089
$1,399,895
$1,153,932
Short-term debt
$345,915
$87,000
$12,360
$2,930,050
$3,090,556
Long-term debt
$0
$0
$105,595
$0
$0
Total liabilities
$345,915
$87,000
$117,955
$2,930,050
$3,090,556
Other
Headcount
—
17
17
17
17

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$20.0M
pre-money
Reg CF · Common · Aug 2023

Blue bars are the pre-money valuation the company stated for a priced round.

Cap table

Share counts as of Apr 17, 2026
ClassOutstandingVotes / shareShare of totalLast price
Common Stock20,000,0001100.0%$1.00Aug 2023

Principal holders% as the filing states it, Aug 8, 2023

  • Forrest Smith100.0%of company
  • Owned Forrest Edward Smith10,638,298 Common Stock53.2%of company
  • Thomas Stanley7,446,809 Common Stock37.2%of company

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $459.7K / $1.2MInvestors 274Post-money $20.5M

Team

4 people
Forrest SmithFounder
Chief Executive Officer, Co-Founder, Board Member

Forrest studied Chinese from the age of 14 and was fascinated with the culture from a very young age. Forrest is fluent in Chinese and has 18 years of experience in successful startup building and executive management in Asia. In 2000, Forrest started his first venture in China, a fabric sourcing company that was acquired in 2002. Over his next ten years in China, Forrest founded and managed multiple ventures from startup to acquisition, including Source Pro Asia (a small sourcing company, August Vale (tannery, leather furniture company acquired by Wilway Holdings), and most recently Illumitron (LED lighting and controls, company acquired by Cooper Lighting). Aside from his founder position in multiple companies, Forrest has held several positions, from Director of Asian Operations for a Fortune 500 company to Director of Business Development. His education includes International Baccalaureate with a focus on Chinese, Nanjing University/Johns Hopkins Center, and Georgia Tech.

Thomas SandersonFounder
Chief Operating Officer, Co-Founder, Board Member

Tom Sanderson is the COO of Kineon. An entrepreneur at heart, driven by a passion for human health and well-being, Tom has worked in international startups for more than 16 years. Born in Bahrain and raised in the North of England. Over 10 years as co-founder of a successful Film Production Studio based out of South East China - providing film services for leading global brands such as Huawei, Sennheiser, Audi, John Lewis... He firmly believes that incorporating mindfulness, health and well-being into your professional and personal life is the key to success.

Edward Douglas SandersonFounder
CFO, Director and Co-Founder
Edward Sanderson
Chief Financial Officer, Board Member

Fellow of the Institute of Chartered Management Accountants. Ed has worked in the UK, Europe and the Middle East providing Board level Financial support over many years.

Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 3 of 3 annual reports (FY2023–FY2025)

274 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARApr 17, 20260001987012-26-000002
    EDGAR
  • Form C-ARApr 14, 20250001665160-25-000656
    EDGAR
  • Form C-ARApr 19, 20240001665160-24-000401
    EDGAR
  • Form C-UDec 1, 20230001665160-23-001965
    EDGAR
  • Form C/AOct 16, 20230001665160-23-001853
    EDGAR
  • Form CAug 8, 20230001665160-23-001617
    EDGAR
Source: ManualCIK 0001987012DEShare price $1.00

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.